Taimei Technology WP
Schizophrenia: Four major clinical trials to watch in 2023
Novel mechanisms and an overlooked symptom target highlight a slate of major schizophrenia clinical trials with readouts expected in 2023.
US FDA releases draft guidance for cancer clinical trials
Syneos Health and KX partner for data-driven insights
Duchenne muscular dystrophy: major trials and events to watch in 2023
Merck reports positive data from malignant pleural mesothelioma trial
30 years of failed trials put sepsis on track to be the main cause of death by 2050
